Mary F. McNaughton Collins, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatitis | 23 | 2010 | 102 | 2.670 |
Why?
|
Pelvic Pain | 12 | 2010 | 274 | 1.320 |
Why?
|
Prostate-Specific Antigen | 12 | 2011 | 2478 | 0.790 |
Why?
|
Mass Screening | 7 | 2014 | 5252 | 0.560 |
Why?
|
Prostatic Neoplasms | 16 | 2011 | 11074 | 0.540 |
Why?
|
Decision Making | 3 | 2014 | 3888 | 0.400 |
Why?
|
Prostatic Hyperplasia | 3 | 2007 | 522 | 0.310 |
Why?
|
Patient Participation | 3 | 2014 | 1457 | 0.300 |
Why?
|
Prostate | 2 | 2006 | 1773 | 0.290 |
Why?
|
Physicians, Family | 1 | 2009 | 345 | 0.290 |
Why?
|
Domestic Violence | 1 | 2007 | 176 | 0.270 |
Why?
|
Urination Disorders | 2 | 2006 | 241 | 0.260 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2014 | 3923 | 0.260 |
Why?
|
Health Care Surveys | 2 | 2014 | 2453 | 0.250 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7281 | 0.240 |
Why?
|
Medication Adherence | 1 | 2014 | 2062 | 0.220 |
Why?
|
Quality of Life | 11 | 2008 | 12805 | 0.220 |
Why?
|
Sex Offenses | 1 | 2007 | 354 | 0.220 |
Why?
|
Urology | 3 | 2002 | 399 | 0.220 |
Why?
|
Chronic Disease | 19 | 2010 | 9147 | 0.210 |
Why?
|
Adrenergic alpha-Antagonists | 3 | 2008 | 174 | 0.210 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3086 | 0.190 |
Why?
|
Cystitis, Interstitial | 3 | 2010 | 61 | 0.180 |
Why?
|
Cost of Illness | 3 | 2007 | 1859 | 0.180 |
Why?
|
False Positive Reactions | 3 | 2009 | 981 | 0.180 |
Why?
|
Antimetabolites | 1 | 2000 | 125 | 0.170 |
Why?
|
Radiation Oncology | 2 | 2002 | 555 | 0.170 |
Why?
|
Allopurinol | 1 | 2000 | 191 | 0.160 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7908 | 0.150 |
Why?
|
Male Urogenital Diseases | 2 | 2009 | 48 | 0.150 |
Why?
|
Family Practice | 1 | 2000 | 516 | 0.140 |
Why?
|
Primary Health Care | 3 | 2011 | 4556 | 0.120 |
Why?
|
Health Status Indicators | 3 | 2005 | 969 | 0.120 |
Why?
|
Male | 41 | 2014 | 350027 | 0.110 |
Why?
|
Orchiectomy | 2 | 2008 | 466 | 0.110 |
Why?
|
Middle Aged | 27 | 2014 | 213367 | 0.100 |
Why?
|
Aged | 22 | 2014 | 163253 | 0.100 |
Why?
|
Androgen Antagonists | 3 | 2008 | 1361 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3395 | 0.100 |
Why?
|
Endpoint Determination | 1 | 2014 | 601 | 0.090 |
Why?
|
American Cancer Society | 1 | 2009 | 61 | 0.090 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2009 | 780 | 0.090 |
Why?
|
Female Urogenital Diseases | 1 | 2009 | 52 | 0.090 |
Why?
|
Biopsy | 3 | 2006 | 6757 | 0.080 |
Why?
|
Adult | 22 | 2014 | 214035 | 0.080 |
Why?
|
Humans | 44 | 2014 | 744220 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2014 | 57768 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2014 | 595 | 0.080 |
Why?
|
Knowledge | 1 | 2009 | 181 | 0.080 |
Why?
|
Advisory Committees | 1 | 2011 | 774 | 0.070 |
Why?
|
Syndrome | 3 | 2009 | 3250 | 0.070 |
Why?
|
Prostatectomy | 4 | 2005 | 1887 | 0.070 |
Why?
|
United States | 16 | 2011 | 69867 | 0.070 |
Why?
|
Preventive Health Services | 1 | 2011 | 575 | 0.070 |
Why?
|
Neoplasms | 2 | 2014 | 21672 | 0.070 |
Why?
|
Translations | 1 | 2005 | 64 | 0.070 |
Why?
|
Health Services Research | 2 | 2004 | 1836 | 0.060 |
Why?
|
Physician-Patient Relations | 3 | 2014 | 3227 | 0.060 |
Why?
|
Child Abuse, Sexual | 1 | 2007 | 383 | 0.060 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1123 | 0.060 |
Why?
|
Urodynamics | 1 | 2005 | 347 | 0.060 |
Why?
|
Self Disclosure | 1 | 2004 | 251 | 0.060 |
Why?
|
Analgesics | 1 | 2010 | 1040 | 0.060 |
Why?
|
Urinalysis | 1 | 2005 | 369 | 0.060 |
Why?
|
Urinary Incontinence | 1 | 2007 | 496 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2004 | 315 | 0.050 |
Why?
|
Quinazolines | 1 | 2008 | 1356 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3611 | 0.050 |
Why?
|
Rest | 1 | 2006 | 901 | 0.050 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2008 | 1187 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2009 | 5396 | 0.050 |
Why?
|
Florida | 1 | 2002 | 435 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2005 | 921 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 187 | 0.040 |
Why?
|
Office Visits | 2 | 2004 | 598 | 0.040 |
Why?
|
Pain Measurement | 2 | 2007 | 3419 | 0.040 |
Why?
|
Physical Examination | 1 | 2005 | 1238 | 0.040 |
Why?
|
Attitude to Health | 2 | 2006 | 2053 | 0.040 |
Why?
|
Adaptation, Psychological | 2 | 2007 | 2576 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2002 | 548 | 0.040 |
Why?
|
Prospective Studies | 6 | 2007 | 53280 | 0.040 |
Why?
|
Canada | 3 | 2010 | 2065 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3509 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 5987 | 0.040 |
Why?
|
Boston | 2 | 2007 | 9311 | 0.040 |
Why?
|
Palpation | 1 | 1997 | 166 | 0.040 |
Why?
|
Brachytherapy | 2 | 2002 | 1246 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2004 | 972 | 0.040 |
Why?
|
Societies, Medical | 1 | 2009 | 3741 | 0.040 |
Why?
|
Prevalence | 3 | 2007 | 15226 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 7179 | 0.030 |
Why?
|
Geriatrics | 1 | 2000 | 396 | 0.030 |
Why?
|
Sulfonamides | 1 | 2004 | 1940 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2009 | 15538 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3800 | 0.030 |
Why?
|
Health Expenditures | 1 | 2007 | 2348 | 0.030 |
Why?
|
Pain | 1 | 2009 | 4987 | 0.030 |
Why?
|
Data Collection | 2 | 2002 | 3340 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2002 | 1509 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3750 | 0.030 |
Why?
|
Health Status | 2 | 2004 | 4034 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2004 | 19907 | 0.030 |
Why?
|
Cohort Studies | 5 | 2007 | 40559 | 0.030 |
Why?
|
Internal Medicine | 1 | 2000 | 1009 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5982 | 0.030 |
Why?
|
Logistic Models | 1 | 2007 | 13409 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2002 | 3528 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2002 | 6893 | 0.030 |
Why?
|
Ultrasonic Therapy | 1 | 1994 | 235 | 0.030 |
Why?
|
Epidemiologic Methods | 2 | 2008 | 1365 | 0.020 |
Why?
|
Incidence | 2 | 2007 | 20945 | 0.020 |
Why?
|
Treatment Failure | 2 | 2008 | 2619 | 0.020 |
Why?
|
Female | 6 | 2014 | 380197 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 1994 | 403 | 0.020 |
Why?
|
Health Care Costs | 1 | 2004 | 3209 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 63119 | 0.020 |
Why?
|
Disease Progression | 1 | 2005 | 13280 | 0.020 |
Why?
|
Research | 1 | 1997 | 1999 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 571 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 3842 | 0.020 |
Why?
|
Health Surveys | 2 | 2009 | 4037 | 0.020 |
Why?
|
Social Support | 2 | 2007 | 2117 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 29050 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14726 | 0.020 |
Why?
|
Urethritis | 1 | 2005 | 22 | 0.020 |
Why?
|
Patient Selection | 1 | 1997 | 4216 | 0.020 |
Why?
|
Direct Service Costs | 1 | 2004 | 62 | 0.020 |
Why?
|
Anger | 1 | 2006 | 402 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2010 | 12035 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2000 | 9960 | 0.010 |
Why?
|
Age Factors | 1 | 2000 | 18367 | 0.010 |
Why?
|
Patients | 1 | 2009 | 900 | 0.010 |
Why?
|
Absenteeism | 1 | 2004 | 250 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2903 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 651 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 2008 | 788 | 0.010 |
Why?
|
Drug Utilization | 1 | 2008 | 1183 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1994 | 3591 | 0.010 |
Why?
|
Health Resources | 1 | 2007 | 911 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
Placebos | 1 | 2004 | 1677 | 0.010 |
Why?
|
Psychometrics | 1 | 2009 | 3002 | 0.010 |
Why?
|
Child | 1 | 2007 | 77679 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2277 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2006 | 1828 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2000 | 25043 | 0.010 |
Why?
|
Risk Factors | 1 | 2005 | 72280 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4841 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2708 | 0.010 |
Why?
|
Hospitalization | 2 | 2007 | 10262 | 0.010 |
Why?
|
Health Education | 1 | 2002 | 1055 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3023 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2005 | 1623 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6485 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12244 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11007 | 0.010 |
Why?
|
Mathematics | 1 | 1994 | 728 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1994 | 498 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 4245 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8628 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13885 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 7659 | 0.000 |
Why?
|
Kinetics | 1 | 1994 | 6474 | 0.000 |
Why?
|
Young Adult | 1 | 2008 | 56436 | 0.000 |
Why?
|
Risk Assessment | 1 | 2002 | 23337 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15161 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 85759 | 0.000 |
Why?
|